FDA Action Alert: Theravance’s Approval, Mallinckrodt and Aquestive

The Food and Drug Administration (FDA) is taking care of a few approvals and committee meetings ahead of the Thanksgiving holiday week. They include drugs for chronic obstructive pulmonary disease, a pain drug, and a sublingual film formulation of a well-known drug for erectile dysfunction. Here’s a look. Theravance’s Revefenacin for COPD Theravance Biopharma, based in Dublin, …